BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
BHVN
Delisted
BHVN was delisted on the 3rd of October, 2022.
224 hedge funds and large institutions have $4.1B invested in Biohaven Pharmaceutical Holding Company Ltd. in 2021 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 82 increasing their positions, 90 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
17% less funds holding in top 10
Funds holding in top 10: 12 → 10 (-2)
26% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 46
Holders
224
Holding in Top 10
10
Calls
$64.1M
Puts
$49.5M
Top Buyers
| 1 | +$49.1M | |
| 2 | +$41.7M | |
| 3 | +$38.1M | |
| 4 |
GCM
Glenview Capital Management
New York
|
+$31.3M |
| 5 |
AC
Armistice Capital
New York
|
+$29.3M |
Top Sellers
| 1 | -$25.3M | |
| 2 | -$16.7M | |
| 3 | -$16.5M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.1M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$15.4M |